Objective: AFP has been used as a surveillance tool for HCC recurrence, but the prognostic
utility of an elevated pretreatment AFP level is poorly defined. This review sought to analyze …

Background and Aims The prognostic ability of α-fetoprotein (AFP) for patients with
hepatocellular carcinoma (HCC) was examined by using different cutoff values. The optimal …

The prognostic impact of serum α-fetoprotein (AFP) level in patients with hepatocellular
carcinoma (HCC) is controversial. This study aimed to investigate the predictive ability of …

Background and aims The role of Alfa-fetoprotein (AFP) in the management of
hepatocellular carcinoma (HCC) is still debated, with differences in recommendations …

Background and Objectives: Serum alpha-fetoprotein (AFP) is a recognized affordable
oncological marker in patients with hepatocellular carcinoma (HCC). However, AFP's …

Introduction Alpha‐fetoprotein (AFP) has a valuable role in postoperative surveillance for
hepatocellular carcinoma (HCC) recurrence. The utility of pretreatment or baseline AFP …

Background: Hepatocellular cancer (HCC) is the fifth most frequently diagnosed cancer in
the world and the second leading cause of cancer-related death across the globe. There are …

The purpose of this study was to conduct a comprehensive study of the clinical correlation
between the alpha-fetoprotein (AFP) level at diagnosis and pathological grades …

Background The clinical value of alpha-fetoprotein (AFP) in patients with AFP-negative (< 20
ng/ml) hepatocellular carcinoma (HCC) who underwent curative resection remained …

Hepatocellular carcinoma (HCC), one of the most common malignant tumors worldwide, is
known for its grim prognosis, with untreated life expectancy being only a matter of months …